In a Phase 1 clinical study, researchers led by EPFL and their partners report that a new liver- and gut-targeted oral drug ...
Researchers developed TLC-2716, a liver- and gut-targeted drug that selectively reduced LXR activity, lowering triglycerides, ...
Asharq Al Awsat A study led by researchers from the Ecole Polytechnique Fédérale de Lausanne (EPFL) in Switzerland, revealed ...
High triglycerides, widely known as an enemy of the aging heart, may not be as threatening to older adults' brains, new research suggests. The study, of over 80,000 older adults, found those with ...